FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> FluBlok | Protein Sciences | flu vaccine

Caterpillar-based flu shot could be on horizon

Tools

The FDA's Vaccines and Related Biological Products Advisory Committee today will determine whether Protein Sciences' flu vaccine FluBlok, which can be produced in less than two months by inserting flu genes into an insect virus and growing it in caterpillar ovary cells, warrants approval.

FluBlok can be produced in a third of the time it takes larger drugmakers, including Sanofi-Aventis, GlaxoSmithKline and Novartis, to make their chicken egg-based shots, according to a Bloomberg article. If approved, FluBlok would represent the first cell-culture derived influenza vaccine licensed in the U.S., according to FDA briefing documents posted ahead of the committee meeting.

FDA documents also revealed that the vaccine was as safe and effective as other shots. The agency made this assessment based on data from four studies of 3,231 adults.

Protein Sciences has grown to 63 employees from 40 in the last three months, and if the vaccine is approved, it may be the smallest company to receive an FDA drug approval, Daniel Adams, Protein Science's CEO, tells Bloomberg. The company may have shots ready for next flu season, he adds.

- read the Bloomberg story 
- check out the FDA briefing documents

Related Articles:
Hamburg offers chicken/egg solution
Protein Sciences wins $150M contract for gene-based vax program


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Comments (2) | Post a comment
More stories about FluBlok   Protein Sciences   flu vaccine  

Comments

The 6-5 vote from the FDA advisory panel stating that PSC had not demonstrated safety of FluBlok is obviously a dissapointment to PSC. Your article is entitled "Catepillar-based flu shot on the horizon", and the question now is how far away is that horizon? It would be interesting to hear the FDA advisory panel's thoughts on the suitable size for a safety database for this product.

"FDA recommended several additional post-licensure studies on pregnant women...children with compromised immune systems." We nearly lost our son at 4 now 6, because of a booster shot, CDC was involved, MRI etc. He no longer receives vaccines because he is immune compromised. FDA thinks that my son should be part of additional trials ... and so should pregnant women. Nice, really brilliant.

Please make certain the there is full efficacy for adults, then perhaps even teenagers before giving it to children or pregnant women.

FDA should provide a license to experiment on adults only ... my son can wait couple of years. And yes, I know the challenges of the industry after 20 years of in it (hence this site)

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.